NCT02070380View on ClinicalTrials.gov

Crossover Comparison of MultiHance and Dotarem

PHASE4CompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Brain Disease
Interventions
DRUG

MultiHance 0.1 mmol/kg

MultiHance administered at 0.1 mmol/kg

DRUG

Dotarem

Dotarem administered at 0.1 mmol/kg

DRUG

MultiHance 0.05 mmol/kg

MultiHance administered at 0.05 mmol/kg

Trial Locations (1)

97330

Samaritan Health Services, Corvallis

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY